SCHEMBL13613651

SCHEMBL13613651

Nc1ccccc1CNC(=O)Nc1cccc2c1CC(O)CC2

nearest known ligand 0.53

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 20/20 0.53
OPRM1 P35372 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13613607 0.87 TRPV1 (0.53) TRPV1OPRM1
SCHEMBL13613613 0.87 TRPV1 (0.57) TRPV1OPRM1
SCHEMBL13613641 0.87 TRPV1 (0.53) TRPV1OPRM1
SCHEMBL13613610 0.87 TRPV1 (0.53) TRPV1OPRM1
SCHEMBL13613667 0.86 MEN1 (0.52) TRPV1OPRM1
SCHEMBL13613632 0.84 LMNA (0.54) TRPV1OPRM1
SCHEMBL13613639 0.84 TRPV1 (0.60) TRPV1OPRM1
SCHEMBL13613606 0.84 TRPV1 (0.59) TRPV1OPRM1
SCHEMBL13613650 0.83 TRPV1 (0.51) TRPV1OPRM1
SCHEMBL13613616 0.80 TRPV1 (0.56) TRPV1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612113-B2 Such as N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-(7-hydroxy-5,6,7,8-tetrahydro-1-naphthalenyl)urea; vanilloid receptor antagonists; for treatment of urge urinary incontinence, overactive bladder, chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, COPD XENTION LIMITED (GB) 2009-11-03 US disclosed
US-7612113-B2 Such as N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-(7-hydroxy-5,6,7,8-tetrahydro-1-naphthalenyl)urea; vanilloid receptor antagonists; for treatment of urge urinary incontinence, overactive bladder, chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, COPD XENTION LIMITED (GB) 2009-11-03 US disclosed